Cardiac Magnetic Resonance Measurements of Area at Risk and Infarct Size in Ischemic Syndromes⁎⁎Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.  by Klocke, Francis J.
C
M
R
I
F
C
T
m
a
o
a
t
w
i
w
l
L
i
f
s
b
v
p
p
e
t
r
t
m
p
t
p
s
t
w
f
w
t
a
r
p
m
a
c
m
C
a
w
g
s
i
f
r
i
d
f
q
p
t
i
t
r
d
S
b
m
r
i
l
t
t
s
s
o
w
(
e
t
w
c
t
p
i
t
T
*
v
A
o
U
Journal of the American College of Cardiology Vol. 55, No. 22, 2010
© 2010 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.01.048EDITORIAL COMMENT
ardiac Magnetic Resonance
easurements of Area at
isk and Infarct Size in
schemic Syndromes*
rancis J. Klocke, MD
hicago, Illinois
his issue of the Journal includes 3 studies that use cardiac
agnetic resonance (CMR) measurements of area at risk
nd infarct size to evaluate myocardial salvage and early
utcomes in acute ischemic syndromes. Two deal with
cutely reperfused ST-segment elevation myocardial infarc-
ion (STEMI) (1,2). The third addresses stabilized patients
ith non–ST-segment elevation syndromes scheduled for
nvasive study (3). Areas at risk for infarction were identified
ith T2-weighted imaging. Infarct size was quantified with
ate gadolinium enhancement (LGE) imaging.
See pages 2459, 2470, and 2480
GE as a predictor of adverse outcomes after myocardial
nfarction. LGE is now an accepted, widely used method
or delineating irreversibly injured myocardium with high
patial resolution (4). Several individual studies, including
oth current reports in STEMI patients (1,2), have ad-
anced the view that LGE measurements during the acute
hase of infarction provide additive value to established
redictors of adverse outcome such as ejection fraction and
nd-systolic volume index. This conclusion is supported by
he recent larger study of Cheong et al. (5) in patients
eferred for CMR imaging in a tertiary referral center. In
his study, which included 857 high-risk patients and a
edian follow-up of 4.4 years, the magnitude of LGE
redicted all-cause mortality after adjustment for age, ejec-
ion fraction, and congestive heart failure. In addition,
atients with ejection fractions 50% showing LGE had
urvival characteristics similar to those with ejection frac-
ions 50% and no LGE.
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Feinberg Cardiovascular Research Institute and the Division of Cardi-5
logy, Department of Medicine, Feinberg School of Medicine, Northwestern
niversity, Chicago, Illinois.The current study of Larose et al. (2) includes 6-month as
ell as acute measurements of LGE infarct size. The
ollow-up measurements averaged 27% less than those made
ithin 12 h after reperfusion. These reductions are similar
o those reported by other groups between the initial week
fter infarction and several months later. They presumably
eflect resolution of acute inflammatory changes and re-
lacement of resorbed tissue by scar. Although serial LGE
easurements during the first several days after infarction
re not available in humans, the relative magnitude of any
hanges is apparently insufficient to negate the value of
easurements during this period.
ombined LGE and T2-weighted imaging: emerging
pplications. Although still an emerging technology, T2-
eighted CMR is being investigated actively by several
roups, often in conjunction with LGE imaging. Areas
howing increased T2 signal are usually larger than areas of
nfarction defined by LGE. The increased T2 signal persists
or days to weeks after infarction and can be accentuated by
eperfusion. It seems to reflect edema in reversibly as well as
rreversibly injured myocardium and can retrospectively
efine the total area at risk of infarction after both reper-
used and nonreperfused acute coronary occlusion (6,7).
The use of combined T2-weighted and LGE imaging to
uantify area at risk as well as infarct size offers attractive
ossibilities. Most initial reports have focused on defining
he proportions of area at risk that have been irreversibly
njured in acutely reperfused STEMI patients. Figure 2 in
he current study of Eitel et al. (1) nicely demonstrates the
apid fall-off in salvageable myocardium known to occur
uring the first several hours after the onset of symptoms in
TEMI. Knowledge of the amount of myocardium that has
een reversibly injured but remains “at risk” might facilitate
anagement decisions in patients in whom immediate
evascularization is not an obvious choice. LGE-positive
mages not accompanied by T2 evidence of edema are more
ikely to represent remote than recent infarction. In clinical
rials of therapies intended to reduce infarct size, the ability
o define the proportion of an area at risk that has been
alvaged (i.e., remains LGE-negative) should reduce sample
ize appreciably.
The current study of Raman et al. (3) extends applications
f combined T2-weighted and LGE imaging to patients
ith non–ST-segment elevation acute coronary syndromes
NSTE-ACS) (i.e., unstable angina and non–ST-segment
levation infarction). Diagnosis required an abnormal serum
roponin-I level or ischemic electrocardiographic changes as
ell suspected cardiac chest pain. All 88 patients who
ompleted the CMR study were pain-free after initial
reatment and had previously been scheduled for angiogra-
hy. Areas of increased T2-weighted signal were apparent
n 65% of patients, and these individuals had higher peak
roponin-I levels than the 35% of patients not showing a
2-weighted abnormality. T2 positivity was also present in
0% (17 of 34) patients without LGE evidence of infarc-
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Risk and Infarct Size in Ischemic Syndromes June 1, 2010:2489–90ion, indicating that ischemia-related edema can be identi-
ed before infarction in at least some cases. Of T2-positive
atients, 88% underwent revascularization (on the basis of
ngiographer judgment without knowledge of CMR find-
ngs), whereas 74% of T2-negative patients did not. Limited
ollow-up information is felt to suggest that T2 positivity is
ssociated with an increased frequency of near-term adverse
ardiac events.
As Raman et al. (3) carefully point out, theirs is a small
bservational study in a stabilized subset of NSTE-ACS
atients and includes relatively few outcome events. Despite
hese limitations, the study’s findings encourage further
xploration of T2-weighted CMR in the broad spectrum of
schemic syndromes. In the STEMI study of Eitel et al. (1),
myocardial “salvage index” (T2 area at risk minus LGE
nfarct size/T2 area at risk) turned out to be the strongest
redictor of short-term adverse cardiac events.
nsettled issues in T2-weighted edema imaging.
lthough cardiac T2-weighted imaging technology has
mproved substantially in recent years, important limitations
emain (8). The studies of Raman et al. (3) and Wright et
l. (9) are encouraging in that images interpreted visually by
onsensus of 2 CMR experts were judged diagnostically
atisfactory in 93% and 91%, respectively, of studies. How-
ver, more robust methods are still needed. Raman et al. (3)
uggest that developing approaches for quantitative T2
apping might prove helpful. Aletras et al. (10) are study-
ng hybrid approaches for reducing artifacts and other
imitations of current technologies.
Implications of T2-negative studies in the setting of
ossible ischemia need careful study. The absence of T2
bnormalities in 35% of the Raman et al. (3) high-risk
STE-ACS patients raises concern about the sensitivity of
urrent technology for identifying ischemia in situations
ther than STEMI. This uncertainty also applies to the
mall group of unstable angina patients included in the
ecent emergency department study of Cury et al. (11). In a
003 study of infarctions induced by septal embolization in
atients with hypertrophic cardiomyopathy (12), increases
n T2 signal were not detected approximately 1 h after
mbolization even though LGE imaging was already
ositive.
An additional consideration is that edema-related in-
reases in T2 signal are influenced by biologic as well as
echnologic factors. Ischemia can produce intracellular as
ell as interstitial edema and inflammatory responses. The
elative contributions of each to an increase in T2 signal
ight vary with the intensity and/or duration of ischemia.
arked increases in T2 signal noted immediately after
eperfusion might involve acute cellular disruption. The
egree to which these differing factors influence the mag-
itude, duration, and time course of myocardial T2 changess unclear and might vary in different clinical situations. iDespite these unresolved issues, T2-weighted imaging is
lready a valuable addition to the CMR evaluation of
yocardial salvage and ischemic syndromes. Further studies
n large, well-defined subsets of ischemia patients will be
eeded to define the additive value of T2-weighted imaging
n specific settings. Experimental studies that might clarify
he relative importance of the various factors capable of
nfluencing T2 signals during and after ischemia also de-
erve high priority. All these studies could benefit substan-
ially from further improvements in T2-weighted imaging
echnology.
eprint requests and correspondence: Dr. Francis J. Klocke, 950
orth Michigan Avenue, Apartment 5102, Chicago, Illinois
0611-7532. E-mail: f-klocke@northwestern.edu.
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